The overactive bladder syndrome: Treating patients on an individual basis

BJU International

Volumn 99, Issue SUPPL. 3, 2007, Pages 1-7

  Cardozo, Linda ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antimuscarinic therapy; Behavioural therapy; Detrusor overactivity; Overactive bladder; Urodynamics; UTI

Indexed keywords

BOTULINUM TOXIN; DARIFENACIN; DESMOPRESSIN; DOXYCYCLINE; OXYBUTYNIN; PLACEBO; PROPIVERINE; SOLIFENACIN; TETRACYCLINE; TOLTERODINE; TROSPIUM CHLORIDE;

BLADDER TRAINING; BLURRED VISION; CLINICAL TRIAL; CONSTIPATION; DRUG RELEASE; ELECTROSTIMULATION; HUMAN; HYPERREFLEXIA; NEUROPATHIC DETRUSOR OVERACTIVITY; OVERACTIVE BLADDER; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; URINARY TRACT INFECTION; URINARY URGENCY; URODYNAMICS; XEROSTOMIA;

BEHAVIOR THERAPY; HUMANS; MUSCARINIC ANTAGONISTS; PATIENT-CENTERED CARE; SYNDROME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE; URODYNAMICS;

EID: 34247209017     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06698.x     Document Type: Review

References (19)

1. Abrams P, Cardojzo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78
2. Fitzgerald MP, Stablein U, Brubaker L. Urinary habits among asymptomatic women. Am J Obstet Gynecol 2002; 187: 1384-8
3. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-6
4. Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-36
5. Jarvis GJ, Hall S, Stamp S, Millar DR, Johnson A. An assessment of urodynamic examination in incontinent women. Br J Obstet Gynaecol 1980; 87:893-6
6. McGuire EJ. Mixed symptomatology. BJU Int 2000; 85 (Suppl. 3): 47-52
7. Cardozo LD, Stanton SL. Genuine stress incontinence and detrusor instability - a review of patients. Br J Obstet Gynaecol 1980; 87: 184-90
8. Versi E, Cardozo L, Anand D, Cooper D. Symptoms analysis for the diagnosis of genuine stress incontinence. Br J Obstet Gynaecol 1991; 98: 815-9
9. Wiskind AK, Miller KF, Wall LL. One hundred unstable bladders. Obstet Gynecol 1994; 83: 108-12
10. Jeffcoate TN, Francis WJ. Urgency incontinence in the female. Am J Obstet Gynecol 1966; 94: 604-18
11. Frewen WK. An objective assessment of the unstable bladder of psychosomatic origin. Br J Urol 1978; 50: 246-9
12. Jarvis GJ, Millar DR. Controlled trial of bladder drill for detrusor instability. Br Med J 1980; 281: 1322-3
13. Berghmans LC, Hendriks HJ, De Bie RA, van Waalwijk van Doorn ES, Bø K, van Kerrebroeck PE. Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials. BJU Int 2000; 85: 254-63
14. Appell RA, Sand P, Dmochowski R et al. Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study. Mayo Clin Proc 2001; 76: 358-63
15. Sussman D, Garely A. Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET). Curr Med Res Opin 2002; 18: 177-84
16. Diokno AC, Appell RA, Sand PK et al.; OPERA Study Group. Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc 2003; 78: 687-95
17. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 1997; 104: 988-93
18. Chapple CR, Yanamishi T, Chess-Williams R. Muscarinic receptor subtypes and management of the overactive bladder. Urology 2002; 60 (Suppl. 1): 82-9
19. Dmochowski RR, Sand PK, Zinner NR, Gittelman MC, Davila GW, Sanders SW; Transdermal Oxybutynin Study Group. Comparative efficacy and safety of transdermal oxybutynin and tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 2003; 62: 237-42